Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients

被引:1
|
作者
Rosa, Vitor Emer Egypto [1 ]
Lopes, Mariana Pezzute [1 ]
Spina, Guilherme Sobreira [1 ]
Soares Junior, Jose [1 ]
Salazar, David [1 ]
Romero, Cristhian Espinoza [1 ]
Lottenberg, Marcos Pita [1 ]
de Santis, Antonio [1 ]
Pires, Lucas Jose Neves Tachotti [1 ]
Goncalves, Luis Fernando Tonello [1 ]
Fernandes, Joao Ricardo Cordeiro [1 ]
Sampaio, Roney Orismar [1 ]
Tarasoutchi, Flavio [1 ]
机构
[1] Univ Sao Paulo, Clin Hosp, Heart Inst InCor, Sao Paulo, Brazil
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
关键词
myocarditis; rheumatic fever; rheumatic heart disease; valvular heart disease; heart failure; FEVER; ECHOCARDIOGRAPHY; DIAGNOSIS; CHILDREN; PREVALENCE;
D O I
10.3389/fcvm.2021.676694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart failure occurs in similar to 10% of patients with acute rheumatic fever (RF), and several studies have shown that cardiac decompensation in RF results primarily from valvular disease and is not due to primary myocarditis. However, the literature on this topic is scarce, and a recent case series has shown that recurrent RF can cause ventricular dysfunction even in the absence of valvular heart disease. Methods: The present study evaluated the clinical, laboratory and imaging characteristics of 25 consecutive patients with a clinical diagnosis of myocarditis confirmed by 18F-FDG PET/CT or gallium-67 cardiac scintigraphy and RF reactivation according to the revised Jones Criteria. Patients underwent three sequential echocardiograms at (1) baseline, (2) during myocarditis and (3) post corticosteroid treatment. Patients were divided according to the presence (Group 1) or absence (Group 2) of reduced left ventricular ejection fraction (LVEF) during myocarditis episodes. Results: The median age was 42 (17-51) years, 64% of patients were older than 40 years, and 64% were women. Between Group 1 (n = 16) and in Group 2 (n = 9), there were no demographic, echocardiographic or laboratory differences except for NYHA III/IV heart failure (Group 1: 100.0% vs. Group 2: 50.0%; p = 0.012) and LVEF (30 [25-37] vs. 56 [49-62]%, respectively; p < 0.001), as expected. Group 1 patients showed a significant reduction in LVEF during carditis with further improvement after treatment. There was no correlation between LVEF and valvular dysfunction during myocarditis. Among all patients, 19 (76%) underwent 18F-FDG PET/CT, with a positive scan in 68.4%, and 21 (84%) underwent gallium-67 cardiac scintigraphy, with positive uptake in 95.2%, there was no difference between these groups. Conclusion: Myocarditis due to rheumatic fever reactivation can cause left ventricular dysfunction despite valvular disease, and it is reversible after corticosteroid treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Left Ventricular Dysfunction and Depression in Hospitalized Patients with Heart Failure
    Freedland, Kenneth E.
    Carney, Robert M.
    Steinmeyer, Brian C.
    Skala, Judith A.
    Rich, Michael W.
    PSYCHOSOMATIC MEDICINE, 2021, 83 (03): : 274 - 282
  • [22] Colchicine ameliorates the chronic inflammatory state in patients with chronic rheumatic valvular heart disease: a pilot study
    Rifaie, Osama
    Badr, Mahmoud
    Salam, Ahmed Abdel
    Galal, Haitham
    EGYPTIAN HEART JOURNAL, 2020, 72 (01)
  • [23] Assessment of global left ventricular function with dual-source computed tomography in patients with valvular heart disease
    Bak, So Hyeon
    Ko, Sung Min
    Jeon, Hae Jeong
    Yang, Hyun Suk
    Hwang, Hweung Kon
    Song, Meong Gun
    ACTA RADIOLOGICA, 2012, 53 (03) : 270 - 277
  • [24] Speckle-tracking parameters as predictors of left ventricular systolic dysfunction in patients with myocarditis
    Cherniuk, S., V
    ZAPOROZHYE MEDICAL JOURNAL, 2018, (04) : 471 - 474
  • [25] Heart rate control in patients with left ventricular systolic dysfunction and heart failure
    Pourdjabbar, Ali
    Dwivedi, Girish
    Haddad, Ruba
    Saikali, Anthony
    Mielniczuk, Lisa
    Haddad, Haissam
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 276 - 277
  • [26] Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience
    Nader, Vanessa
    Matta, Anthony
    Canitrot, Ronan
    Itier, Romain
    Salameh, Pascale
    Lairez, Olivier
    Elbaz, Meyer
    Galinier, Michel
    Azar, Rania
    Roncalli, Jerome
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [27] Antibodies to cardiolipin and hemostasis in rheumatic patients in developing rheumatic valvular disease
    Bobkov, VA
    Myasoedova, SE
    Lebedeva, AV
    TERAPEVTICHESKII ARKHIV, 1997, 69 (12) : 12 - 15
  • [28] Circulating endothelial cells in patients with heart failure and left ventricular dysfunction
    Martinez-Sales, Vicenta
    Sanchez-Lazaro, Ignacio
    Vila, Virtudes
    Almenar, Luis
    Contreras, Teresa
    Reganon, Edelmiro
    DISEASE MARKERS, 2011, 31 (02) : 75 - 82
  • [29] Clinical and Socio-Demographic Profiles of Patients Seen with Rheumatic Heart Disease in a Cardiac Clinic of a Tertiary Hospital in Ghana
    Owusu, Isaac Kofi
    Acheamfour-Akowuah, Emmanuel
    Wiafe, Yaw Amo
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2022, 13 : 85 - 93
  • [30] Left ventricular dysfunction in atrial fibrillation and heart failure risk
    Kuo, Jen-Yuan
    Chang, Sheng-Hsiung
    Sung, Kuo-Tzu
    Chi, Po-Ching
    Liao, Jo-Nan
    Chao, Tze-Fan
    Su, Cheng-Huang
    Yeh, Hung-, I
    Hung, Chung-Lieh
    ESC HEART FAILURE, 2020, 7 (06): : 3694 - 3706